THIS PHASE I EFFORT WILL EXPLORE THREE STABILIZATION STRATEGIES--DIRECTED MUTAGENESIS, POLYMER-BASED NANOPA…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- W911NF25PA012
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Department of the Army
- Award amount
- $209,542
- Period of performance
- Aug 18, 2025 – Feb 17, 2026
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- AL
Public award description
THIS PHASE I EFFORT WILL EXPLORE THREE STABILIZATION STRATEGIES--DIRECTED MUTAGENESIS, POLYMER-BASED NANOPARTICLE ENCAPSULATION, AND COVALENT ENZYME FUNCTIONALIZATION--TO GENERATE ROBUST PTE-BASED THERAPEUTICS READY FOR PHASE II DEVELOPMENT.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Agency: Department of Defense
- PSC AJ11 — Product Service Code AJ11
- Federal market intelligence software